| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 76282-737-60 | 76282-737 | HUMAN PRESCRIPTION DRUG | darunavir | darunavir 600 mg | TABLET | ORAL | 20240119 | N/A | ANDA | ANDA206288 | EXELAN PHARMACEUTICALS INC. | DARUNAVIR HYDRATE | 600 mg/1 | 60 TABLET in 1 BOTTLE (76282-737-60) |
| 76282-738-30 | 76282-738 | HUMAN PRESCRIPTION DRUG | darunavir | darunavir 800 mg | TABLET | ORAL | 20240119 | N/A | ANDA | ANDA206288 | EXELAN PHARMACEUTICALS INC. | DARUNAVIR HYDRATE | 800 mg/1 | 30 TABLET in 1 BOTTLE (76282-738-30) |
| 69097-244-02 | 69097-244 | HUMAN PRESCRIPTION DRUG | Darunavir 600 and 800 mg | darunavir | TABLET | ORAL | 20231129 | N/A | ANDA | ANDA206288 | Cipla USA Inc. | DARUNAVIR HYDRATE | 800 mg/1 | 30 TABLET in 1 BOTTLE (69097-244-02) |
| 69097-248-03 | 69097-248 | HUMAN PRESCRIPTION DRUG | Darunavir 600 and 800 mg | darunavir | TABLET | ORAL | 20231129 | N/A | ANDA | ANDA206288 | Cipla USA Inc. | DARUNAVIR HYDRATE | 600 mg/1 | 60 TABLET in 1 BOTTLE (69097-248-03) |